0 items USD 0.00Search
Your search for "global markets direct epithelial ovarian cancer pipeline review h1 2016" gave back 85729 results.
Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of...
Catalog:
LPI
January 2023
Price: USD 3,660.00
PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP). They are developed for multiple...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Liposome doxorubicin is a commonly used anthracycline anti-tumor drug, and is one of the first-line drugs for ovarian cancer. Publisher' newest...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global PARP (Poly ADP-Ribose Polymerase) Inhibitor market size was valued at US$ 4584.5 million in 2023. With growing demand in downstream market...
Catalog:
LPI
January 2024
Price: USD 3,660.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Fluorouracil Injection market will undergo major changes...
Catalog:
Arsta
March 2022
Price: USD 3,360.00
The global Platinum based Cancer Drug market size was valued at US$ 1508.4 million in 2023. With growing demand in downstream market, the Platinum...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and...
Catalog:
GIR
April 2023
Price: USD 3,480.00
The global Liposomal Doxorubicin market size was valued at US$ 1244.9 million in 2023. With growing demand in downstream market, the Liposomal...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Summary Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents...
Catalog:
HYR
June 2022
Price: USD 1,800.00
Liposome doxorubicin is a commonly used anthracycline anti-tumor drug, and is one of the first-line drugs for ovarian cancer. The global Liposomal...
Catalog:
GIR
September 2024
Price: USD 3,480.00
The “Gynecological Cancers Drug Industry Forecast” looks at past sales and reviews total world Gynecological Cancers Drug sales in 2022, providing a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Targeting DNA Repair Drugs market size was valued at USD 615.3 million in 2022 and is forecast to a readjusted size of USD 1629.7 million...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The “Flucytosine Tablets Industry Forecast” looks at past sales and reviews total world Flucytosine Tablets sales in 2022, providing a comprehensive...
Catalog:
LPI
March 2023
Price: USD 3,660.00
PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP). The “PARP Inhibitors for Cancer Industry...
Catalog:
LPI
March 2023
Price: USD 3,660.00
